Bdparib Rucaparib, is a cutting-edge poly(ADP-ribose) polymerase (PARP) inhibitor. Its primary function is to target specific enzymes that are responsible for repairing DNA damage within cancer cells. By blocking these enzymes, Bdparib puts a wrench in the gears of the cancer cell’s repair machinery, ultimately leading to its demise. Key Facts and Analysis Proven Efficacy: […]
You are here: Home / Archives for 2023